Taiwan Liposome Company, Ltd. Equity
Taiwan Liposome Company, Ltd. had Equity of TWD 863.33 million as of 2020-12-31, per its 20-F filed 2021-03-30.
Discontinued › Notes
ifrs-full:Equity · last filed 2021-03-30
- 2020-12-31: Equity 863.33M TWD.
- 2019-12-31: Equity 721.91M TWD.
- 2018-12-31: Equity 669.20M TWD.
- 2017-12-31: Equity 987.28M TWD.
TWD
| Period end | Equity |
|---|---|
| 2020-12-31 | 863.33M TWD 20-F · filed 2021-03-30 |
| 2019-12-31 | 721.91M TWD 20-F · filed 2021-03-30 |
| 2018-12-31 | 669.20M TWD 20-F · filed 2021-03-30 |
| 2017-12-31 | 987.28M TWD 20-F · filed 2021-03-30 |
| 2016-12-31 | 1.80B TWD 20-F · filed 2020-03-10 |
| 2015-12-31 | 2.49B TWD 20-F · filed 2019-04-30 |
USD
| Period end | Equity |
|---|---|
| 2020-12-31 | $30.75M 20-F · filed 2021-03-30 |
| 2019-12-31 | $24.14M 20-F · filed 2020-03-10 |
| 2018-12-31 | $21.86M 20-F · filed 2019-04-30 |
| 2017-12-31 | $987.28M 20-F · filed 2019-04-30 |